This section explains what OCP is, how it develops, and why partnership with your eye care team matters.
OCP is a chronic autoimmune disorder in which the immune system mistakenly attacks healthy tissue in the conjunctiva and other mucous membranes. The resulting inflammation leads to scarring that can compromise the cornea and vision.
The disease is idiopathic, meaning it has no known external cause. Patients cannot prevent its onset, and lifestyle factors do not appear to trigger it.
OCP most often appears in middle aged or older adults and is more common in women. It typically affects both eyes.
Diagnosis relies on clinical examination, the use of diagnostic dyes to reveal scarring, and confirmation with a biopsy of affected tissue.
Because OCP is progressive and prone to relapse, ongoing monitoring is vital to slow scarring and protect vision.
Inflammation from OCP directly harms the conjunctiva and cornea, leading to dryness and vision changes.
The conjunctiva covers the white part of the eye. When inflamed, it becomes dry and irritated, causing discomfort and redness.
Untreated inflammation can advance to the cornea, producing scars that cloud vision and, in severe cases, lead to blindness.
While the disease is idiopathic, certain traits place patients at higher risk.
Advancing age and female gender are associated with a greater likelihood of developing OCP.
Because risk factors are not modifiable, routine eye examinations are the best way to detect OCP early and limit vision loss.
Patients may notice several warning signs that prompt an eye evaluation.
The symptoms below often appear as inflammation progresses.
Without treatment, OCP can cause several serious problems.
Persistent dryness can blur vision and create constant discomfort.
Inward turned lashes may scrape the cornea, producing scars, infections, or ulcers.
Corneal damage can lead to pain, light sensitivity, and vision loss.
Inflammation may contribute to a difficult to treat form of glaucoma that threatens the optic nerve.
While there is no cure, careful management controls inflammation and preserves sight.
The main objectives are to reduce inflammation, slow scarring, relieve symptoms, and protect vision.
Immunomodulatory drugs suppress the immune response enough to limit tissue damage and prevent corneal scarring.
Several eye drop options target dryness and inflammation.
Managing the eyelids helps prevent mechanical injury.
Special lenses shield the cornea and improve dryness.
When scarring is severe, additional steps may be required.
The answers below address common concerns about OCP.
Your doctor reviews your medical history, checks vision, applies diagnostic dyes to highlight scarring, measures tear production, and confirms findings with a biopsy.
Similar presentations include chemical burns, graft versus host disease, Sjogren syndrome, Stevens Johnson syndrome, and sarcoidosis.
Yes, patients may develop blistering or scarring on the skin, in the mouth, genitals, or intestinal tract, wherever mucosal tissue is present.
OCP is progressive and can lead to blindness. Detecting it early allows treatment that preserves vision and reduces discomfort.
